Family history is recognized widely as a significant risk factor for t
he development of breast cancer. A gene (BRCA1), mutations in which co
nfer susceptibility to early-onset breast and ovarian cancer, has been
mapped to chromosome 17q12-21. An intensive search for this gene is c
urrently underway in a number of laboratories. Recent data support the
hypothesis that BRCA1 is a tumor suppressor gene that may be importan
t in the development of both inherited and sporadic breast and ovarian
cancers. Genetic and physical maps of the BRCA1 candidate region larg
ely have been completed and efforts are being directed at identificati
on of candidate genes from within this region. A small number of famil
ies recently have received results of genetic-linkage testing, indicat
ing which family members likely are to be carriers of a germline BRCA1
mutation, and, therefore, have a lifetime risk of developing breast c
ancer of approximately 85%. The imminent isolation of BRCA1 will make
predictive testing for breast cancer a reality for many women and like
ly will pave the way for novel diagnostic and therapeutic strategies i
n the future.